Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Robert P. Giugliano
Based on 16 articles published since 2009
(Why 16 articles?)
||||
Expertise Level
The expertise of Robert P. Giugliano ranks in the
  • Top 0.11%
  • ... of 27,392 published authors worldwide on Hypercholesterolemia
  • ... from 2009 through 2019
  • ... based on contributions to 16 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Harvard University Boston   Contact    
2017
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: · Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo, Norway. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Molecular Medicine, University of Pavia and Cardiac Intensive Care Unit and Laboratories for Experimental Cardiology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy. · Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw, Warsaw, Poland. · Center of Preventive Cardiology, 3rd Department Internal Medicine, University General Hospital and 1st Medical Faculty, Prague, Czech Republic. · 1st Department of Medicine, University of Pécs, Pécs, Hungary. · Polyclinic for Endocrinology, Diabetes, and Preventive Medicine, University of Cologne, Cologne, Germany. · Lipids and Atherosclerosis Unit, Maimonides Biomedical Research Institute of Cordoba, Reina Sofia University Hospital, University of Cordoba, CIBEROBN, Cordoba, Spain. · University Hospital Center Besançon, Besançon, France. · Hopital Cantonal, Hopitaux Universitaires de Geneva, Geneva, Switzerland. · Rhode Island Hospital, Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA. · Amgen, Thousand Oaks, CA, USA. · Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. · International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK. · Pubmed 28859947
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Deputy Editor. · Pubmed 28768310
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W., S.A.M., J.F.K.) · Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.) · Amgen, Thousand Oaks, CA (N.H., H.W., T.L., S.M.W.) · International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London (P.S.S.) · and Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo (T.R.P.). · Pubmed 28304224
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Deputy Editor, JAMA Cardiology. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Lipid Clinic, Oslo University Hospital, Oslo, Norway. · Amgen Inc, Thousand Oaks, California. · The Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg, South Africa. · Pubmed 28291870
  • Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, Yale-New Haven Health Services Corporation, New Haven, Connecticut. · Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Amgen Inc, Thousand Oaks, California. · Amgen Inc, Thousand Oaks, California5currently with AbbVie Inc, North Chicago, Illinois. · Pubmed 28122070
  • Brigham and Women’s Hospital, Boston, MA · · Warren Alpert Medical School of Brown University, Providence, RI · Pubmed 29141161
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
2010
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 20400493
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 16 total) written by Robert P. Giugliano about Hypercholesterolemia:

  • Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial. 2017
  • Low-Density Lipoprotein Cholesterol Treatment in the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Era: Getting Back on Target. 2017
  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. 2017
  • Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension Study. 2017
  • Association Between Circulating Baseline Proprotein Convertase Subtilisin Kexin Type 9 Levels and Efficacy of Evolocumab. 2017
  • Cognitive Function in a Randomized Trial of Evolocumab. 2017
  • Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful? 2016
  • Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. 2015
  • AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). 2014
  • Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial. 2014
Show List of Full Article Records
Google Searches

Learn more about Robert P. Giugliano using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University Boston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University Boston
2017
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. Electronic address: · Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo, Norway. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Molecular Medicine, University of Pavia and Cardiac Intensive Care Unit and Laboratories for Experimental Cardiology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy. · Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw, Warsaw, Poland. · Center of Preventive Cardiology, 3rd Department Internal Medicine, University General Hospital and 1st Medical Faculty, Prague, Czech Republic. · 1st Department of Medicine, University of Pécs, Pécs, Hungary. · Polyclinic for Endocrinology, Diabetes, and Preventive Medicine, University of Cologne, Cologne, Germany. · Lipids and Atherosclerosis Unit, Maimonides Biomedical Research Institute of Cordoba, Reina Sofia University Hospital, University of Cordoba, CIBEROBN, Cordoba, Spain. · University Hospital Center Besançon, Besançon, France. · Hopital Cantonal, Hopitaux Universitaires de Geneva, Geneva, Switzerland. · Rhode Island Hospital, Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA. · Amgen, Thousand Oaks, CA, USA. · Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia. · International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK. · Pubmed 28859947
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. · Deputy Editor. · Pubmed 28768310
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W., S.A.M., J.F.K.) · Sydney Medical School, National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.) · Amgen, Thousand Oaks, CA (N.H., H.W., T.L., S.M.W.) · International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London (P.S.S.) · and Oslo University Hospital, Ullevål and Medical Faculty, University of Oslo, Oslo (T.R.P.). · Pubmed 28304224
  • Jacksonville Center for Clinical Research, Jacksonville, Florida. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts3Deputy Editor, JAMA Cardiology. · Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Lipid Clinic, Oslo University Hospital, Oslo, Norway. · Amgen Inc, Thousand Oaks, California. · The Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Parktown, Johannesburg, South Africa. · Pubmed 28291870
  • Section of Cardiovascular Medicine, Department of Medicine, Yale School of Medicine, New Haven, Connecticut2Center for Outcomes Research and Evaluation, Yale-New Haven Health Services Corporation, New Haven, Connecticut. · Thrombolysis in Myocardial Infarction Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Amgen Inc, Thousand Oaks, California. · Amgen Inc, Thousand Oaks, California5currently with AbbVie Inc, North Chicago, Illinois. · Pubmed 28122070
  • Brigham and Women’s Hospital, Boston, MA · · Warren Alpert Medical School of Brown University, Providence, RI · Pubmed 29141161
2015
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.) · the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa · the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.) · the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.) · Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott) · Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2014
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. · Division of Cardiovascular Medicine, University of California at San Francisco, San Francisco, California. · Amgen, Inc., Thousand Oaks, California. · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: · Pubmed 24161333
  • Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.) · TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (R.P.G., M.S.S.) · Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (F.J.R.) · Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Camperdown, Australia (D.S.) · Bethesda Health Research Center, Bethesda, MD (M.B.) · Lipid Clinic, Oslo University Hospital, Oslo, Norway (G.L.) · Hospital Universitario Miguel Servet, Zaragoza, Spain (F.C.) · and Amgen Inc, Thousand Oaks, CA (R.S., P.N., T.L., R.S., S.M.W.). · Pubmed 24255061
2012
  • TIMI Study Group, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 23141813
2013
  • TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 23884353
2012
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22714699
2010
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. · Pubmed 20400493
Unspecified
2017
  • Brigham and Women’s Hospital, Boston, MA · · Warren Alpert Medical School of Brown University, Providence, RI · Pubmed 29141161
3 Other Locations Show
Yearly article counts 00611232010
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.